share_log

Morgan Stanley Downgrades Nevro to Underweight, Lowers Price Target to $4

Benzinga ·  Dec 2 22:00  · Ratings

Morgan Stanley analyst Cecilia Furlong downgrades Nevro (NYSE:NVRO) from Equal-Weight to Underweight and lowers the price target from $9 to $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment